33 -3 (53) 2023 — Kim V.S., Abdullayeva L.M. — VACCINATIONAGAINSTCOVID — 19 ANDPREGNANCY

VACCINATIONAGAINSTCOVID – 19 ANDPREGNANCY

Kim V.S., Samarqand State Medical University

Abdullayeva L.M. Tashkent Medical Academy

Resume

Vaccination against COVID-19 is strongly recommended for pregnant women. It should be offered to pregnant women in the same way as to the rest of the population, depending on age and the presence of clinical risk factors. Women in the postpartum period should be offered vaccination in accordance with the recommendations for the (non-pregnant) population as a whole. The recommendation of the Joint Committee on Vaccination and Immunization (JCVI), published on December 30, 2020, states that there is no evidence of a risk when vaccinating against COVID-19 nursing women

Keywords: Vaccination against COVID-19 and pregnancy, recommendations of the Joint Committee on Vaccinations and Immunization (JCVI).

First page

186

Last page

190

For citation: Kim V.S., Abdullayeva L.M. – VACCINATIONAGAINSTCOVID – 19 ANDPREGNANCY //New Day in Medicine 3(53)2023 186-190 https://goo.su/xmMEb

LIST OF REFERENCES:

  1. Abu-Raddad LJ, Chemaitelly H, Butt AA. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. // N Engl J Med 2021; 385(2):187-189.
  2. Allotey J, Stallings E, Bonet M,Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. // BMJ 2020; 370:m3320
  3. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. // N Engl J Med 2021; 384(5):403-416
  4. Bernal JL, Andrews N, Gower C, Gallagher E, Simmons R,Thelwall S, et al. : Effectiveness of COVID-19 vaccines against the B.1.617.2 variant. medRxiv 2021; Website
  5. British Fertility Society/Association of Reproductive and Clinical Scientists. BFS & ARCS Covid-19 Vaccines & Fertility – updated FAQs. 2021; Website
  6. Centers for Disease Control and Prevention.V-safe COVID-19 Vaccine Pregnancy Registry. 2021; Website
  7. Centers for Disease Control and Prevention. Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination. Updated May 2021. 2021; Website
  8. Cines DB, Bussel JB. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. // N Engl J Med 2021;384(23):2254-2256
  9. ClinicalTrials.gov. A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) (HORIZON 1). 2021; Website
  10. ClinicalTrials.gov. Study to Evaluate the Safety,Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older. 2021; Website
  11. Collier A-RY, McMahan K,Yu J,Tostanoski LH, Aguayo R, Ansel J, et al. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women. // JAMA 2021; 325(23):2370-2380
  12. Flannery DD, Gouma S, Dhudasia MB, Mukhopadhyay S, Pfeifer MR, Woodford EC, et al. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. // JAMA Pediatr 2021; 175(6):594-600
  13. Golan Y, Prahl M, Cassidy A, Wu AHB, Jigmeddagva U, Lin CY et al. Immune response during lactation after anti-SARS-CoV2 mRNA vaccine. medRxiv 2021
  14. Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B,Young N, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. // Am J Obstet Gynecol 2021;S0002-9378(21)00187-3
  15. Gurol-Urganci I, Jardine JE, Carroll F, Draycott T, Dunn G, Fremeaux A, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. // Am J Obstet Gynecol 2021; S0002- 9378(21)00565-2
  16. Ikegame S., Siddiquey M.N.A., Hung CT. et al. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants (англ.).

file

download